Novel application of pharmaceutical composition in preparation of drugs for treating depression

Abstract

The invention discloses a novel application of a pharmaceutical composition in the preparation of drugs for treating depression. The pharmaceutical composition comprises the following components by weight: 15 to 30 grams of platycladi seed, 10 to 20 grams of gynostemma pentaphylla, 10 to 15 grams of rosemary, and 5 to 10 grams of pearl.

Description

technical field [0001] The invention relates to a new application of a pharmaceutical composition for treating depression, belonging to the technical field of medicine. Background technique [0002] Depression (depression) is a group of syndromes characterized by significant and persistent low mood. It is one of the common mental diseases. Sin, poor diet and sleep, worrying about suffering from various diseases, feeling discomfort in many parts of the body, and in severe cases, suicidal thoughts and behaviors may appear. At present, an average of 11.3% of adults in the world suffer from depression every year, and the number of patients with depression in my country is as high as 36 million, which is the highest in the world. Therefore, depression will become the No. 1 killer of human mental illness in the 21st century, and it needs to be highly valued by the society. [0003] The etiology and pathogenesis of depression are intricate and have not been fully elucidated. Cur...

AI Technical Summary

Problems solved by technology

The above-mentioned technical scheme is characterized by complex ingredients, which is not conducive to the deployment and use of pharmaceutical compositions.

Images